Indianapolis-based drugmaker Eli Lilly and Company has announced price reductions of 70% for its most commonly prescribed insulins, as well as expansion of its Insulin Value Program, capping ...

Another significant reason that Lilly is able to take such action is that the products which will have their price cut, such as Humalog (insulin lispro), are already seeing their sales fall ...

Develop business strategies by understanding the trends shaping and driving Insulin Pens market. Drive revenues by understanding the key trends, innovative products and technologies, market ...

Diabetes is one of the major non-communicable diseases (NCDs). (Image Credits: Pixabay) The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin ...

As the number of people diagnosed with diabetes continues to grow, an increasing number of products marketed under the guise of "dietary supplements" or "over-the-counter drugs" promising to ...

president of Eli Lilly diabetes and obesity, in an interview. Medicare beneficiaries are also not eligible for Eli Lilly's savings card programs for Zepbound. Jonsson said "in an ideal world," the ...

(The Hill) – A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro.

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs ... some compounded products aren’t FDA ...

They say over the past two-plus decades, they’ve overpaid millions of dollars for insulin through their employees’ health plans. So, they’re suing the manufacturers including Lilly ...